XNAS
PRE
Market cap381mUSD
Oct 08, Last price
22.00USD
1D
-2.09%
1Q
23.18%
IPO
-80.83%
Name
Prenetics Global Ltd
Chart & performance
P/E
—
P/S
4.05
EPS
—
Div yield, %
—
Shrs. gr., 5y
13.69%
Rev. gr., 5y
7.23%
Revenues
92m
+201.72%
Net income
-38m
L-18.56%
CFO
-22m
L-24.46%
Dividend
Feb 17, 20160.0602 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Artisan Acquisition Corp. is currently inactive, lacking any substantial business operations. Its primary objective is to complete a strategic integration with one or more existing enterprises, which could manifest as a merger, equity exchange, asset acquisition, stock purchase, or another form of corporate restructuring. The company's search for a suitable target will concentrate on entities with established activities or significant potential within the healthcare, consumer goods, and technology sectors. Established in 2021, the firm is headquartered in Grand Cayman, Cayman Islands.
Key people
Sheng Wu Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Hoi Chun Lo
Chief Financial Officer · since 2018
Yung Ho Wong
Chief Technology Officer
Chi Hung Tzang
Co-Founder, Chief Scientific Officer
Jordan Lemerande
Vice President - Product Development · since 2023
Alan Thomas
Vice President, Supply Chain & Operations · since 2024
Samantha Kwok
Chief of Staff to Group Chief Executive Officer, Vice President - People and Operations · since 2023
Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Senthil Sundaram
Chief Clinical Officer
Andy Cheung
Director · since 2025
Independent Director · since 2023
Independent Director
Independent Director · since 2024
David Vanderveen
Independent Director · since 2024
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||